compound introduction
Eribaxaban (PD348292, PD0348292) is an oral factor Xa inhibitor, it is expected to develop for the treatment and prevention of thrombotic disease.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Eribaxaban
CAS number：536748-46-6 molecular formula：C24H22ClFN4O4
overview
Specs
| Chinese alias | 艾瑞沙班 | ||
| English alias | 5FCH6YDY7Z | PD-348292 | PD0348292 | PD-0348292 | PD 348,292 | (2R,4R)-1-N-(4-chlorophenyl)-2-N-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide | PD348292 | CHEMBL476186 | Eribaxaban (USAN) | Eribaxaban [USAN] | ||
| CAS number | 536748-46-6 | molecular formula | C24H22ClFN4O4 |
| molecular weight | 484.91 g/mol | Exact mass | - |
| PSA | 91.000 Ų | logp | 2.900 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
